Natco Pharma Ltd.

Natco Pharma’s Kothur Formulation facility has been found acceptable by United States Food and Drug Administrator (USFDA). The company has received a letter dated July 14, 2014 after completing review of the Establishment Inspection Report (EIR) for the inspection conducted from May 19 to 23, 2014. The facility was classified as acceptable.

The company has made proposed commitments and corrective actions based on the minor and routine observations during inspection. It continues to manufacture and sell products in the US.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.